We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Gartner
IT
$8.84B
| $368K | ﹤0.01% |
2,427
-1,623
| -40% | -$225K |
|
1477
Martin Marietta Materials
MLM
$33.1B
| $368K | ﹤0.01% |
1,831
-796
| -30% | -$149K |
|
|
AVTA
1478
DELISTED
Avantax, Inc. Common Stock
AVTA
| $367K | ﹤0.01% |
11,002
+254
| +2% | +$7.4K |
|
1479
Allison Transmission
ALSN
$9.87B
| $366K | ﹤0.01% |
8,154
-5,160
| -39% | -$245K |
|
|
ALXN
1480
DELISTED
Alexion Pharmaceuticals
ALXN
| $365K | ﹤0.01% |
2,699
-1,489
| -36% | -$185K |
|
|
PGTI
1481
DELISTED
PGT, Inc.
PGTI
| $364K | ﹤0.01% |
26,291
+5,981
| +29% | +$94.7K |
|
1482
Eagle Materials
EXP
$6.28B
| $363K | ﹤0.01% |
4,301
-1,181
| -22% | -$85.3K |
|
1483
Fox Factory Holding Corp
FOXF
$780M
| $363K | ﹤0.01% |
5,194
+144
| +3% | +$9.13K |
|
1484
Kforce
KFRC
$1.03B
| $363K | ﹤0.01% |
10,342
+1,917
| +23% | +$66.5K |
|
1485
Mattel
MAT
$4.18B
| $363K | ﹤0.01% |
27,924
-4,408
| -14% | -$58.9K |
|
1486
Integra LifeSciences
IART
$1.46B
| $362K | ﹤0.01% |
6,502
-399,417
| -98% | -$20.3M |
|
1487
Flowserve
FLS
$8.77B
| $360K | ﹤0.01% |
7,982
-10,445
| -57% | -$456K |
|
1488
RE/MAX Holdings
RMAX
$218M
| $360K | ﹤0.01% |
9,349
+665
| +8% | +$25.5K |
|
1489
US Foods
USFD
$21.2B
| $360K | ﹤0.01% |
10,311
-11,033
| -52% | -$378K |
|
1490
Cactus
WHD
$3.89B
| $359K | ﹤0.01% |
10,071
-4,917
| -33% | -$168K |
|
|
CMD
1491
DELISTED
Cantel Medical Corporation
CMD
| $358K | ﹤0.01% |
+5,354
| New | +$405K |
|
1492
Ventas
VTR
$47.2B
| $357K | ﹤0.01% |
5,587
-2,981
| -35% | -$186K |
|
|
TIVO
1493
DELISTED
Tivo Inc
TIVO
| $357K | ﹤0.01% |
38,323
+429
| +1% | +$4.45K |
|
|
MCRN
1494
DELISTED
Milacron Holdings Corp.
MCRN
| $355K | ﹤0.01% |
31,401
+6,761
| +27% | +$89.4K |
|
1495
Dentsply Sirona
XRAY
$2.66B
| $354K | ﹤0.01% |
7,145
-1,798
| -20% | -$79.2K |
|
1496
Skyworks Solutions
SWKS
$9.5B
| $352K | ﹤0.01% |
4,273
-635
| -13% | -$49K |
|
1497
Interparfums
IPAR
$3.91B
| $351K | ﹤0.01% |
4,625
-864
| -16% | -$60.5K |
|
1498
Associated Banc-Corp
ASB
$5.8B
| $348K | ﹤0.01% |
16,287
-5,337
| -25% | -$118K |
|
|
FRGI
1499
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $347K | ﹤0.01% |
26,441
+5,387
| +26% | +$79.6K |
|
|
DNKN
1500
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $347K | ﹤0.01% |
4,620
-4,446
| -49% | -$311K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.